BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20354172)

  • 1. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia.
    van Galen JC; Kuiper RP; van Emst L; Levers M; Tijchon E; Scheijen B; Waanders E; van Reijmersdal SV; Gilissen C; van Kessel AG; Hoogerbrugge PM; van Leeuwen FN
    Blood; 2010 Jun; 115(23):4810-9. PubMed ID: 20354172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
    Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress.
    Yuniati L; van der Meer LT; Tijchon E; van Ingen Schenau D; van Emst L; Levers M; Palit SA; Rodenbach C; Poelmans G; Hoogerbrugge PM; Shan J; Kilberg MS; Scheijen B; van Leeuwen FN
    Oncotarget; 2016 Jan; 7(3):3128-43. PubMed ID: 26657730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
    Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
    Tissing WJ; Meijerink JP; Brinkhof B; Broekhuis MJ; Menezes RX; den Boer ML; Pieters R
    Blood; 2006 Aug; 108(3):1045-9. PubMed ID: 16574952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia.
    Rainer J; Lelong J; Bindreither D; Mantinger C; Ploner C; Geley S; Kofler R
    Mol Endocrinol; 2012 Jan; 26(1):178-93. PubMed ID: 22074950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
    Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
    J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
    Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
    Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor.
    Schmidt S; Irving JA; Minto L; Matheson E; Nicholson L; Ploner A; Parson W; Kofler A; Amort M; Erdel M; Hall A; Kofler R
    FASEB J; 2006 Dec; 20(14):2600-2. PubMed ID: 17077285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
    Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
    Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
    Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of glucocorticoid receptor isoforms expression in acute lymphoblastic leukemia correlate with glucocorticoid resistance.
    Sun X; Fang M; Guan Y; Si Y; Ma L; Wang Y; Jia Z
    Pharmazie; 2015 May; 70(5):316-21. PubMed ID: 26062300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.
    Ichijo T; Chrousos GP; Kino T
    Mol Cell Endocrinol; 2008 Feb; 283(1-2):19-31. PubMed ID: 18096310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by
    Li J; Hlavka-Zhang J; Shrimp JH; Piper C; Dupéré-Richér D; Roth JS; Jing D; Casellas Román HL; Troche C; Swaroop A; Kulis M; Oyer JA; Will CM; Shen M; Riva A; Bennett RL; Ferrando AA; Hall MD; Lock RB; Licht JD
    Cancer Discov; 2022 Jan; 12(1):186-203. PubMed ID: 34417224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant cell-permeable small peptides to modulate glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
    Geng CD; Vedeckis WV
    Biochemistry; 2010 Oct; 49(41):8892-901. PubMed ID: 20831260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
    Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
    Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia.
    Gallagher KM; Roderick JE; Tan SH; Tan TK; Murphy L; Yu J; Li R; O'Connor KW; Zhu J; Green MR; Sanda T; Kelliher MA
    Blood Adv; 2020 Jul; 4(13):3154-3168. PubMed ID: 32658986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.